Molecular Partners AG

NASDAQ: MOLN · Real-Time Price · USD
3.45
-0.07 (-1.99%)
At close: Aug 15, 2025, 3:43 PM
3.53
2.27%
After-hours: Aug 15, 2025, 04:04 PM EDT

Molecular Partners Balance Sheet Statement

Financials in CHF. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
63.87M 67.31M 87.95M 71.81M
Short-Term Investments
85.56M 119.58M 161.2M 61M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a -7.51M 1K
Receivables
286K 1.75M 1.7M 25.73M
Inventory
n/a n/a n/a 2.00
Other Current Assets
2.31M n/a n/a n/a
Total Current Assets
154.28M 192.46M 254.75M 164.19M
Property-Plant & Equipment
4.2M 5.68M 7.24M 8.15M
Goodwill & Intangibles
49K 212K 271K 330K
Total Long-Term Assets
4.25M 5.89M 7.51M 8.48M
Total Assets
158.53M 198.35M 262.26M 172.67M
Account Payables
679K 410K 997K 4.86M
Deferred Revenue
n/a 4.33M 6.41M 28.31M
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
n/a n/a n/a n/a
Total Current Liabilities
10.79M 14.42M 17.25M 46.87M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
4.88M 5.06M 2.55M 6.74M
Total Long-Term Liabilities
6.11M 7.51M 9.84M 18.51M
Total Liabilities
16.89M 21.92M 27.09M 65.38M
Total Debt
2.44M 3.65M 4.85M 6.04M
Common Stock
4.04M 3.63M 3.6M 3.23M
Retained Earnings
-246.29M -191.75M -127.78M -250.95M
Comprehensive Income
n/a 0.00 -981K n/a
Shareholders Equity
141.64M 176.43M 235.17M 107.29M
Total Investments
85.56M 119.58M 161.2M 61M